Latest Antiretroviral drug Stories

A clinical trial that revitalized HIV research tops the journal's list of advances in 2011 The journal Science has lauded an eye-opening HIV study, known as HPTN 052, as the most important scientific breakthrough of 2011. This clinical trial demonstrated that people infected with HIV are 96 percent less likely to transmit the virus to their partners if they take antiretroviral drugs (ARVs). The findings end a long-standing debate over whether ARVs could provide a double benefit by...

CHAPEL HILL, N.C., Dec. 22, 2011 /PRNewswire/ -- The HIV Prevention Trials Network 052 study, led by Myron S. Cohen, M.D. of the University of North Carolina at Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science. To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/53909-unc-hiv-prevention-research-scientific-breakthrough-of-year (Photo: http://photos.prnewswire.com/prnh/20111222/MM26343 ) HPTN 052...

Discovery offers new research avenues for fighting this global epidemic Gladstone Institutes scientist Nevan Krogan, PhD, today is announcing research that identifies how HIV—the virus that causes AIDS—hijacks the body's own defenses to promote infection. This discovery could one day help curb the spread of the HIV/AIDS pandemic. Dr. Krogan conducted this research in his laboratory at the University of California, San Francisco (UCSF)—a leading medical school with which Gladstone...

Hundreds of connections between viral and human proteins identified in UCSF-led study -- work that may reveal new drug targets In perhaps the most comprehensive survey of the inner workings of HIV, an international team of scientists led by researchers at the University of California, San Francisco has mapped every apparent physical interaction the virus makes with components of the human cells it infects—work that may reveal new ways to design future HIV/AIDS drugs. Explored this...

MILFORD, Mass., Dec. 21, 2011 /PRNewswire/ -- At a ceremony coinciding with the 20th anniversary of Los Angeles Laker Marvin "Magic" Johnson's public revelation that he had acquired HIV, the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences acknowledged Waters Corporation (NYSE: WAT) for its donation of a state-of-the-art ACQUITY® TQD System, a liquid chromatograph/mass spectrometer that will be used to build laboratory capacity and advance...

Among people recently infected with HIV, immediate antiretroviral therapy (ART) appears preferable to deferring treatment, according to a new study published in the Journal of Infectious Diseases and now available online. Although the benefits of ART during early HIV-1 infection remain unproven, the findings support growing evidence favoring earlier ART initiation. Christine Hogan, MD, of the Medical College of Wisconsin in Milwaukee, led a team of researchers from various institutions to...

Less than one-quarter (23%) of children with HIV/AIDS who need treatment are getting it, according to a report released by the World Health Organization (WHO) on the occasion of World AIDS Day (1 December 2011). Although treatment coverage for adults has been steadily climbing and has now reached approximately half of those in need, coverage for children is lagging far behind, highlighted the Drugs for Neglected Diseases initiative (DNDi), a non-profit research and development organization...

Results of clinical trial in Uganda suggest better way to spend money fighting disease in rural Africa A cheaper laboratory test that helps guide anti-retroviral drug treatment for people with HIV/AIDS may be just as effective as a more sophisticated test, a group of international researchers has found – a discovery that could be particularly important in rural Africa. While the findings by researchers in the United States, Canada and Uganda must still be confirmed through additional...

American Academy of HIV Medicine, American Geriatrics Society and the AIDS Community Research Initiative of America Release Best Practices for Managing Multi-Morbidity WASHINGTON, Nov. 30, 2011 /PRNewswire-USNewswire/ -- On the eve of World AIDS Day, the American Academy of HIV Medicine (AAHIVM), the American Geriatrics Society (AGS) and the AIDS Community Research Initiative of America (ACRIA) released the first clinical treatment strategies for managing older HIV patients: The...

(Ivanhoe Newswire) – A rare type of HIV-infection -- group N -- has been diagnosed in a man in France who recently travelled to Togo, meaning that it has been detected outside Cameroon for the first time. This type of HIV infection is much more similar to the virus type found in chimpanzees than it is to other types circulating in humans. HIV in humans is usually group M, or less common, group O.  Since 1998 only 12 cases of group N, including two couples infected by the same strains,...